(1)
Bowers, N.; Porosnicu, M. Increased PD-L1 Tumor Expression Correlates With High Rate of Response to PD-1 Inhibitors in Patients With Unresectable, Recurrent, and Metastatic Cutaneous Squamous Cell Carcinoma. J of Skin 2021, 5, 22-24.